Skip to main content
. 2022 Sep 29;60(3):2102288. doi: 10.1183/13993003.02288-2021

TABLE 2.

Association between type 2 (T2) asthma phenotypes and clinical features

Participants Atopy-only Eos-only T2-high T2-low p-value
Children: wheeze (age <6 years) 219 40 31 37 111
 Female 12 (30.0) 11 (35.5) 10 (27.0) 38 (34.2) 0.8260
 BMI (kg·m−2) 16.32±1.75 16.68±1.65 16.16±1.77 16.44±1.53 0.2987
 Passive smoker 1 (2.6) 1 (3.2) 2 (5.4) 4 (3.6) 0.9267
 Maternal history of asthma 3 (7.9) 3 (10.3) 11 (29.7) 27 (24.8) 0.0345
 Paternal history of asthma 7 (18.4) 6 (20.7) 9 (24.3) 18 (16.5) 0.7565
 Eczema 13 (32.5) 2 (6.5) 21 (56.8) 16 (14.4) <0.0001
 Hay fever 8 (20.0) 0 (0.0) 11 (29.7) 1 (0.9) <0.0001
 Sum of sIgE 102.93±157.99c,d,d 6.57±0.18d,d 199.57±166.49c,d,d 6.63±0.39d,d <0.0001
 Siblings 29 (72.5) 21 (67.7) 28 (75.7) 65 (58.6) 0.1732
 Daycare 31 (81.6) 19 (61.3) 33 (89.2) 80 (72.1) 0.0369
 Eosinophil counts (cells·µL−1) 262.4±138.8a,d,d 821.9±498.4d,d 893.4±355.0d,d 208.6±124.3a,d,d <0.0001
 Neutrophil counts (cells·µL−1) 3164.5±1193.4 3622.9±1187.7 3750.7±1640.4 3408.7±1488.8 0.3147
Children: asthma (age ≥6 years) 254 105 6 102 41
 Female 42 (40.0) 2 (33.3) 29 (28.4) 17 (41.5) 0.2832
 BMI (kg·m−2) 21.24±6.22b 18.67±3.00 18.90±4.16b 20.20±5.37 0.0116
 Passive smoker 20 (19.6) 0 (0.0) 12 (11.8) 4 (10.0) 0.2162
 Maternal history of asthma 25 (24.8) 0 (0.0) 28 (27.7) 12 (29.3) 0.4636
 Paternal history of asthma 22 (21.8) 0 (0.0) 25 (24.8) 6 (14.6) 0.3280
 Eczema 45 (42.9) 1 (16.7) 49 (48.0) 8 (19.5) 0.0079
 Hay fever 58 (55.2) 1 (16.7) 59 (57.8) 3 (7.3) <0.0001
 Sum of sIgE 148.11±126.58a,c,d 6.84±0.43c,c 194.67±156.64a,c,d 6.59±0.27d,d <0.0001
 Siblings 79 (75.2) 6 (100.0) 80 (78.4) 30 (73.2) 0.4919
 Eosinophil counts (cells·µL−1) 256.6±124.4d 591.0±145.5a,d 804.5±330.4a,d,d 225.4±112.6d,d <0.0001
 Neutrophil counts (cells·µL−1) 3795.0±2335.9 3644.8±1520.8 3636.0±1799.3 3341.5±953.5 0.9943
Adults: asthma 211 83 36 52 40
 Female 51 (61.4) 22 (61.1) 20 (38.5) 26 (65.0) 0.0268
 BMI (kg·m−2) 28.11±5.62 27.95±7.38 27.66±4.90 27.39±5.38 0.9355
 Active smoker 6 (7.2) 0 (0.0) 3 (6.0) 4 (10.0) 0.3369
 Ex-smoker 37 (44.6) 18 (50.0) 18 (34.6) 20 (50.0)
 Never-smoker 40 (48.2) 28 (50.0) 31 (59.6) 16 (40.0)
 Maternal history of asthma 12 (14.5) 2 (5.6) 3 (5.8) 7 (17.5) 0.1645
 Paternal history of asthma 10 (12.0) 4 (11.1) 5 (9.6) 2 (5.0) 0.6680
 Eczema 3 (3.6) 0 (0.0) 6 (11.5) 0 (0.0) 0.0169
 Hay fever 62 (74.7) 10 (27.8) 46 (88.5) 8 (20.0) <0.0001
 Sum of sIgE 88.50±95.65a,d,d 12.98±0.06d,d 170.31±215.69a,d,d 13.01±0.14d,d <0.0001
 Eosinophil counts (cells·µL−1) 182.6±96.4d,d 660.9±418.7d,d 607.4±285.4d,d 161.6±94.2d,d <0.0001
 Neutrophil counts (cells·µL−1) 4650.4±2294.8 5272.1±2609.5 4636.1±1705.3 5259.6±2874.9 0.2791

Data are presented as n, n (%) or mean±sd, unless otherwise stated. Eos: eosinophils; BMI: body mass index; sIgE: specific immunoglobulin E. p-values are based on Chi-squared and Kruskal–Wallis tests; the symbols indicate for which phenotypes the continuous variables significantly differ. a: p<0.05, b: p<0.01, c: p<0.001, d: p<0.0001 for contrasts (Wilcoxon test). Plain, underlined, bold and italic symbols indicate for which phenotypes the continuous variables significantly differ.